A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

PHASE4CompletedINTERVENTIONAL
Enrollment

398

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Urinary Incontinence
Interventions
DRUG

solifenacin succinate

Oral

DRUG

tamsulosin

oral

DRUG

placebo

oral

Trial Locations (74)

10016

New York

10021

New York

11530

Garden City

12601

Poughkeepsie

13760

Endwell

14127

Orchard Park

14642

Rochester

15401

Uniontown

17011

Camp Hill

17604

Lancaster

19004

Bala-Cynwyd

19020

Bensalem

23454

Virginia Beach

27103

Winston-Salem

28025

Concord

28601

Hickory

29464

Mt. Pleasant

29681

Simpsonville

30060

Marietta

30076

Roswell

30078

Snellville

30328

Sandy Springs

30342

Atlanta

30513

Blue Ridge

32114

Daytona Beach

32308

Tallahassee

32803

Orlando

32806

Orlando

33027

Pembroke Pines

33028

Pembroke Pines

33414

Wellington

33761

Clearwater

33908

Fort Myers

34652

New Port Richey

35209

Birmingham

37203

Nashville

39202

Jackson

45212

Cincinnati

45249

Cincinnati

47714

Evansville

49544

Grand Rapids

67207

Wichita

71106

Shreveport

73008

Bethany

73071

Norman

77024

Houston

80012

Aurora

80033

Wheat Ridge

80210

Denver

83814

Coeur d'Alene

84121

Salt Lake City

84403

Ogden

85050

Phoenix

85712

Tuscon

90211

Beverly Hills

90232

Culver City

90320

Buena Park

90505

Torrance

90620

Buena

92084

Mission Hills

92108

San Diego

92404

San Bernardino

92869

Orange

93720

Fresno

94027

Atherton

95350

Modesto

95608

Carmichael

97477

Springfield

98043

Mountain Lake Terrace

99202

Spokane

06708

Danbury

02115

Boston

02472

Watertown

07052

West Orange

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00333112 - A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. | Biotech Hunter | Biotech Hunter